Attached are the LOINC codes that we requested for use in the HL72.7.1/EDXL-TEP 1.1 transform. These are TRIAL vs. ACTIVE (see message below) so that we have the opportunity to review them, but we can implement
them in our transform while they are in the TRIAL status.
Patti
Patti Iles Aymond, PhD
Senior Scientist, Research & Development
IEM
8710 Jefferson Highway
Baton Rouge, LA 70809
(225) 526-8844 (voice and fax)
From: Deckard, Jamalynne [mailto:jkdeckar@regenstrief.org]
Sent: Wednesday, December 16, 2015 8:49 AM
To: Aymond, Patti
Cc: submissions@loinc.org
Subject: RE: New Terms Request
Hi Patti,
Your submitted request has been completed. Please review the attached Completed files – a pdf report and spreadsheet – containing the new terms.
The terms currently have a status of TRIAL (vs. ACTIVE) in the LOINC database since they were created shortly before the database was frozen for the official December release, and I didn’t have time to send them
back to you to review until now. A TRIAL status allows us to review and make modification if necessary – however the meaning of the terms will remain the same and so they can be implemented. Prior to the June release, we can change the status from TRIAL
to ACTIVE once the terms have been reviewed.
Let me know if you have any questions.
Thanks!
Jami
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Jamalynne Deckard, MS
| LOINC Content Developer
We’ve moved!
Our new headquarters:
1101 West Tenth Street
Indianapolis, IN 46202
jkdeckar@regenstrief.org |
www.loinc.org | Twitter: @LOINC
LOINC is free, but invaluable. Donate today to give back and help support the cause. Visit
http://members.loinc.org/donate
Confidentiality Notice: The contents of this message and any files transmitted with it may contain confidential and/or privileged information and are intended solely for the use of the named addressee(s).
Additionally, the information contained herein may have been disclosed to you from medical records with confidentiality protected by federal and state laws. Federal regulations and State laws prohibit you from making further disclosure of such information
without the specific written consent of the person to whom the information pertains or as otherwise permitted by such regulations. A general authorization for the release of medical or other information is not sufficient for this purpose.
If you have received this message in error, please notify the sender by return e-mail and delete the original message. Any retention, disclosure, copying, distribution or use of this information
by anyone other than the intended recipient is strictly prohibited.
From: Aymond, Patti [mailto:Patti.Aymond@iem.com]
Sent: Friday, November 20, 2015 3:51 PM
To: Deckard, Jamalynne
Subject: RE: New Terms Request
Thanks, Jami,
·
Reference ID Mapping_77
o
The contingencyMedicalSpecialtyCode is a term that is utilized and understood the type of bed needed at the receiving hospital (e.g., pediatric, burn, psychiatric)
o
The evacuationDestinationRequired term is used to communicate the level of care required at the receiving hospital (e.g., critical care, acute care)
o
A child that requires intensive care would have a contingencyMedicalSpecialtyCode value of “pediatric” and an evacuationDestinationRequired value of “critical care”.
·
Rederence ID Mapping_273
o
TEP is used for the tracking of patients that are being transported via Emergency Services. It does not accommodate the use case of self-transportation or patient discharge.
Please let me know if you need any further clarification.
Patti
Patti Iles Aymond, PhD
Senior Scientist, Research & Development
IEM
8710 Jefferson Highway
Baton Rouge, LA 70809
(225) 526-8844 (voice and fax)
From: Deckard, Jamalynne [mailto:jkdeckar@regenstrief.org]
Sent: Friday, November 20, 2015 1:10 PM
To: Aymond, Patti
Subject: Re: New Terms Request
Hi Patti,
We have a couple questions. Please see the attached pdf.
Thanks!
Jami
From: Aymond, Patti <Patti.Aymond@iem.com>
Sent: Wednesday, November 18, 2015 10:10 AM
To: Deckard, Jamalynne
Subject: RE: New Terms Request
Excellent. Thanks for the update.
Patti
Patti Iles Aymond, PhD
Senior Scientist, Research & Development
IEM
8710 Jefferson Highway
Baton Rouge, LA 70809
(225) 526-8844 (voice and fax)
From: Deckard, Jamalynne [mailto:jkdeckar@regenstrief.org]
Sent: Wednesday, November 18, 2015 9:07 AM
To: Aymond, Patti
Subject: RE: New Terms Request
Hi Patti,
Just a quick update…we are actively working on the submission and will let you know if we have questions. At this time, we have the information needed. We still plan to have them processed in time for the release.
Thanks,
Jami
From: Aymond, Patti [mailto:Patti.Aymond@iem.com]
Sent: Wednesday, October 07, 2015 10:27 AM
To: Deckard, Jamalynne
Cc: 'Werner B Joerg <wjoerg@netessence.com> (wjoerg@netessence.com)'; 'John A. Roberts'; Elysa Jones (elysajones@yahoo.com);
submissions@loinc.org
Subject: RE: New Terms Request
Thanks for the update Jami.
Patti
Patti Iles Aymond, PhD
Senior Scientist, Research & Development
IEM
8710 Jefferson Highway
Baton Rouge, LA 70809
(225) 526-8844 (voice and fax)
From: Deckard, Jamalynne [mailto:jkdeckar@regenstrief.org]
Sent: Tuesday, October 06, 2015 1:44 PM
To: Aymond, Patti
Cc: 'Werner B Joerg <wjoerg@netessence.com> (wjoerg@netessence.com)'; 'John A. Roberts'; Elysa Jones (elysajones@yahoo.com);
submissions@loinc.org
Subject: RE: New Terms Request
Hi Patti,
Our goal is to have your terms included in the next official release of the LOINC database (December). I am not certain when they will be processed prior to that timeframe, but we will send the terms as soon
as they are ready. We are currently processing a backlog of term requests, so apologies for the delay.
Thanks,
Jami
Jami Deckard, MS
LOINC Content Developer
Biomedical Informatics | Regenstrief Institute, Inc.
Health Information and Translational Sciences Bldg. (HITS)
410 W 10ths St., Suite 2000 |Indianapolis, IN 46202
PH: 317.274.9071 | C: 651.319.2944 |
www.loinc.org
Boost your LOINCing. Support a noble cause. Become a LOINC Premium Member today at
http://members.loinc.org
Confidentiality Notice: The contents of this message and any files transmitted with it may contain confidential and/or privileged information and are intended solely for the use of the named addressee(s).
Additionally, the information contained herein may have been disclosed to you from medical records with confidentiality protected by federal and state laws. Federal regulations and State laws prohibit you from making further disclosure of such information
without the specific written consent of the person to whom the information pertains or as otherwise permitted by such regulations. A general authorization for the release of medical or other information is not sufficient for this purpose. If you have received
this message in error, please notify the sender by return e-mail and delete the original message. Any retention, disclosure, copying, distribution or use of this information by anyone other than the intended recipient is strictly prohibited.
From: Aymond, Patti [mailto:Patti.Aymond@iem.com]
Sent: Tuesday, October 06, 2015 10:49 AM
To: Holck, Catherine; 'submissions@loinc.org'
Cc: 'Werner B Joerg <wjoerg@netessence.com> (wjoerg@netessence.com)'; 'John A. Roberts'; Elysa Jones (elysajones@yahoo.com)
Subject: RE: New Terms Request
Katy,
Members of the OASIS Emergency Management Technical Committee are meeting this week with the HL7 Public Health and Emergency Response Working Group to finalize the mapping between our two standards. The new terms
requested in this submission are needed for that mapping. Can you give me an estimated timeframe that we can expect to have the new terms added to the LOINC table?
Many thanks,
Patti
Patti Iles Aymond, PhD
Senior Scientist, Research & Development
IEM
8710 Jefferson Highway
Baton Rouge, LA 70809
(225) 526-8844 (voice and fax)
From: Holck, Catherine [mailto:cholck@regenstrief.org]
Sent: Tuesday, July 28, 2015 8:05 PM
To: Aymond, Patti; 'submissions@loinc.org'
Cc: 'Werner B Joerg <wjoerg@netessence.com> (wjoerg@netessence.com)'; 'John A. Roberts'
Subject: RE: New Terms Request
Hello Patti,
Thank you for the submission. We will probably have requests/questions when we begin processing.
Best Regards,
Katy Holck MT(ASCP) MPH
LOINC Content Developer
Confidentiality Notice: The contents of this message and any files transmitted with it may contain confidential and/or privileged information and are intended solely for the use of the named addressee(s).
Additionally, the information contained herein may have been disclosed to you from medical records with confidentiality protected by federal and state laws. Federal regulations and State laws prohibit you from making further disclosure of such information
without the specific written consent of the person to whom the information pertains or as otherwise permitted by such regulations. A general authorization for the release of medical or other information is not sufficient for this purpose. If you have received
this message in error, please notify the sender by return e-mail and delete the original message. Any retention, disclosure, copying, distribution or use of this information by anyone other than the intended recipient is strictly prohibited.
From: Aymond, Patti [mailto:Patti.Aymond@iem.com]
Sent: Tuesday, July 28, 2015 2:54 PM
To: submissions@loinc.org
Cc: Werner B Joerg <wjoerg@netessence.com> (wjoerg@netessence.com); John A. Roberts
Subject: New Terms Request
If you have any questions or need any additional information, please do not hesitate to contact me.
Patti
Patti Iles Aymond, PhD
Senior Scientist, Research & Development
IEM
8710 Jefferson Highway
Baton Rouge, LA 70809
(225) 526-8844 (voice and fax)